Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-κB

Genes to Cells

Volumn 11, Issue 2, 2006, Pages 177-191

  Okamoto, Kazuo ^a   Fujisawa, Jun Ichi ^b   Reth, Michael ^c   Yonehara, Shin ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FAS LIGAND; FLICE INHIBITORY PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; MUTANT PROTEIN; RNA; TAX PROTEIN; TRANSCRIPTION FACTOR NFAT;

APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; LOXP SITE; NONHUMAN; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION; VIRUS TYPING; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CELL LINE, TUMOR; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MUTATION; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; RNA INTERFERENCE; T-LYMPHOCYTES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; LENTIVIRUS; MUS MUSCULUS;

EID: 33645893189     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2006.00927.x     Document Type: Article

References (39)

1. Brown, P.H., Alani, R., Preis, L.H., Szabo, E. & Birrer, M.J. (1993) Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8, 877-886.
2. Ghosh, D. (1993) Status of the transcription factors database (TFD). Nucleic Acids Res. 21, 3117-3118.
3. Good, L., Maggirwar, S.B. & Sun, S.C. (1996) Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element. EMBO J. 15, 3744-3750.
4. Gyobu, H., Tsuji, T., Suzuki, Y., et al. (2004) Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor. Cancer Res. 64, 1490-1495.
5. Haruyama, H., Ito, S., Miyadai, K., et al. (2002) Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment. Biol. Pharm. Bull. 25, 1537-1545.
6. Hogan, P.G., Chen, L., Nardone, J. & Rao, A. (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205-2232.
7. Huang, D.C., Hahne, M., Schroeter, M., et al. (1999) Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x (L). Proc. Natl. Acad. Sci. USA 96, 14871-14876.
8. Ichikawa, K., Yoshida-Kato, H., Ohtsuki, M., et al. (2000) A novel murine anti-human Fas mAb which mitigates lymphadenopathy without hepatotoxicity. Int. Immunol. 12, 555-562.
9. Iwakura, Y., Itagaki, K., Ishitsuka, C., et al. (1998) The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen. J. Immunol. 161, 6592-6598.
10. Iwakura, Y., Tosu, M., Yoshida, E., et al. (1991) Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253, 1026-1028.
11. Jeang, K.T. (2001) Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: Cellular signaling through NF-kappa B. Cytokine Growth Factor Rev. 12, 207-217.
12. Kishi, S., Saijyo, S., Arai, M., et al. (1997) Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J. Exp. Med. 186, 57-64.
13. Krammer, P.H. (2000) CD95's deadly mission in the immune system. Nature 407, 789-795.
14. Lee, K.K., Ohyama, T., Yajima, N., Tsubuki, S. & Yonehara, S. (2001) MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J. Biol. Chem. 276, 19276-19285.
15. Matsuoka, M. (2005) Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2, 27.
16. Mizushima, S. & Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322.
17. Mori, N., Fujii, M., Cheng, G., et al. (2001) Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor- kappaB and c-AMP responsive element binding protein pathways. Virus Genes 22, 279-287.
18. Mori, N., Nunokawa, Y., Yamada, Y., Ikeda, S., Tomonaga, M. & Yamamoto, N. (1999) Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. Blood 94, 2862-2870.
19. Murakami, A., Shen, H., Ishida, S. & Dickson, C. (2004) SOX7 and GATA-4 are competitive activators of Fgf-3 transcription. J. Biol. Chem. 279, 28564-28573.
20. Nagata, S. (1997) Apoptosis by death factor. Cell 88, 355-365.
21. Nakagiri, S., Murakami, A., Takada, S., Akiyama, T. & Yonehara, S. (2005) Viral FLIP Enhances Wnt Signaling Downstream of Stabilized {beta}-Catenin, Leading to Control of Cell Growth. Mol. Cell. Biol. 25, 9249-9258.
22. Nicot, C., Mahieux, R., Takemoto, S. & Franchini, G. (2000) Bcl-X (L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 96, 275-281.
23. Olive, M., Krylov, D., Echlin, D.R., Gardner, K., Taparowsky, E. & Vinson, C. (1997) A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis. J. Biol. Chem. 272, 18586-18594.
24. Rinkenberger, J.L. & Korsmeyer, S.J. (1997) Errors of homeostasis and deregulated apoptosis. Curr. Opin. Genet. Dev. 7, 589-596.
25. Rivera, I., Harhaj, E.W. & Sun, S.C. (1998) Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J. Biol. Chem. 273, 22382-22388.
26. Rivera-Walsh, I., Waterfield, M., Xiao, G., Fong, A. & Sun, S.C. (2001) NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. J. Biol. Chem. 276, 40385-40388.
27. Shimizu, T., Kawakita, S., Li, Q.H., Fukuhara, S. & Fujisawa, J. (2003) Human T-cell leukemia virus type 1 Tax protein stimulates the interferon-responsive enhancer element via NF-kappaB activity. FEBS Lett. 539, 73-77.
28. Tahara-Hanaoka, S., Sudo, K., Ema, H., Miyoshi, H. & Nakauchi, H. (2002) Lentiviral vector-mediated transduction of murine CD34(-) hematopoietic stem cells. Exp. Hematol. 30, 11-17.
29. Tamiya, S., Etoh, K., Suzushima, H., Takatsuki, K. & Matsuoka, M. (1998) Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 91, 3935-3942.
30. Tanaka, Y., Masuda, M., Yoshida, A., et al. (1992) An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies. AIDS Res. Hum. Retroviruses 8, 227-235.
31. Thome, M. & Tschopp, J. (2001) Regulation of lymphocyte proliferation and death by FLIP. Nature Rev. Immunol. 1, 50-58.
32. Tsukahara, T., Kannagi, M., Ohashi, T., et al. (1999) Induction of Bcl-x (L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J. Virol. 73, 7981-7987.
33. Watanabe, T. (1997) HTLV-1-associated diseases. Int. J. Hematol. 66, 257-278.
34. Watanabe, K., Okamoto, K. & Yonehara, S. (2004) Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP. Cell Death Differ. 12, 10-18.
35. Wingender, E., Chen, X., Fricke, E., et al. (2001) The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29, 281-283.
36. Yonehara, S. (2002) Death receptor Fas and autoimmune disease: From the original generation to therapeutic application of agonistic anti-Fas monoclonal antibody. Cytokine Growth Factor Rev. 13, 393-402.
37. Yonehara, S., Ishii, A. & Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
38. Yoshida, M., Nosaka, K., Yasunaga, J., Nishikata, I., Morishita, K. & Matsuoka, M. (2004) Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 103, 2753-2760.
39. Zhang, Y., Riesterer, C., Ayrall, A.M., Sablitzky, F., Littlewood, T.D. & Reth, M. (1996) Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 24, 543-548.